Zhejiang Provincial Key Laboratory of Medical Genetics, Key Laboratory of Laboratory Medicine, Ministry of Education, China, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Zhejiang Provincial Key Laboratory of Medical Genetics, Key Laboratory of Laboratory Medicine, Ministry of Education, China, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Anal Chim Acta. 2022 Aug 15;1221:340132. doi: 10.1016/j.aca.2022.340132. Epub 2022 Jul 4.
MicroRNAs (miRNAs) and p53 gene can serve as valuable biomarkers for the diagnosis of a variety of cancers. Nevertheless, although the development of the DNA nanostructure on the detection of cancer-related biomarkers was initially demonstrated several years ago, the challenges of developing simpler, cheaper, and multi-level detection DNA biosensors persist. Herein, based on the rolling circle amplification (RCA) coupled with the target-triggered skill, we have developed a well-designed detecting platform. In this study, the dumbbell-shaped probes (DPP) could be cyclized and initiated through targets, thus beginning the target-catalyst RCA (tc-RCA) reaction, therefore engendering numerous dumbbell probe amplicons (DPA). Thereafter the probe primers (PP) mutually complementary to the loop of DPA was introduced, leading to the branch strand displacement reaction (B-SDA). SYBR Green I can effectively bind to the amplified double-stranded structures as a fluorescent reporter. Altering the target-binding sequence of the DPP, this biosensor can also be applied to detect different biomarkers. As a consequence, target miR-21 and p53 gene can be detected down to 0.65 fM and 2.04 fM respectively with a wide dynamic range. Moreover, we have also achieved the qualitative detection of interesting targets in cell lysates as well as the complex biological substrates and compared the results with reverse transcription quantitative PCR (RT-qPCR), thereby indicating the potential application in clinical diagnosis and biomedical research.
微小 RNA(miRNA)和 p53 基因可以作为多种癌症诊断的有价值的生物标志物。然而,尽管几年前就已经初步展示了基于 DNA 纳米结构的癌症相关生物标志物检测技术,但开发更简单、更便宜和多层次检测 DNA 生物传感器的挑战仍然存在。在此,我们基于滚环扩增(RCA)结合目标触发技术,开发了一个精心设计的检测平台。在这项研究中,哑铃形探针(DPP)可以通过目标进行环化和引发,从而开始目标催化 RCA(tc-RCA)反应,从而产生大量哑铃探针扩增子(DPA)。此后,引入与 DPA 环互补的探针引物(PP),导致分支链位移反应(B-SDA)。SYBR Green I 可以作为荧光报告物有效地结合到扩增的双链结构上。通过改变 DPP 的靶结合序列,该生物传感器还可以用于检测不同的生物标志物。因此,miR-21 和 p53 基因的靶标可以分别检测到低至 0.65 fM 和 2.04 fM 的浓度,具有较宽的动态检测范围。此外,我们还实现了对细胞裂解物中感兴趣目标以及复杂生物基质的定性检测,并与逆转录定量 PCR(RT-qPCR)的结果进行了比较,表明其在临床诊断和生物医学研究中有潜在的应用价值。